Safety and Efficacy of Thalidomide Vs Hydroxyurea in β-Thalassemia patients: A Systematic Review of Current Evidence. Pharm Pract (Granada) [Internet]. 2025 Apr. 3 [cited 2025 Oct. 3];23(2):1-7. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/3177